{"id":12556,"date":"2013-04-07T08:45:17","date_gmt":"2013-04-07T12:45:17","guid":{"rendered":"http:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/research-and-markets-psoriasis-pipeline-review-h1-2013\/"},"modified":"2013-04-07T08:45:17","modified_gmt":"2013-04-07T12:45:17","slug":"research-and-markets-psoriasis-pipeline-review-h1-2013","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/transhuman-news-blog\/psoriasis\/research-and-markets-psoriasis-pipeline-review-h1-2013\/","title":{"rendered":"Research and Markets: Psoriasis &#8211; Pipeline Review, H1 2013"},"content":{"rendered":"<p><p>    DUBLIN--(BUSINESS WIRE)--  <\/p>\n<p>    Research and Markets (<a href=\"http:\/\/www.researchandmarkets.com\/research\/8rr8vz\/psoriasis\" rel=\"nofollow\">http:\/\/www.researchandmarkets.com\/research\/8rr8vz\/psoriasis<\/a>)    has announced the addition of the     \"Psoriasis - Pipeline Review, H1 2013\" report to their    offering.  <\/p>\n<p>    This report provides information on the therapeutic development    for Psoriasis, complete with latest updates, and special    features on late-stage and discontinued projects. It also    reviews key players involved in the therapeutic development for    Psoriasis.  <\/p>\n<p>    Psoriasis - Pipeline Review, Half Year is built using data and    information sourced from Global Markets Direct's proprietary    databases, Company\/University websites, SEC filings, investor    presentations and featured press releases from    company\/university sites and industry-specific third party    sources, put together by Global Markets Direct's team.  <\/p>\n<p>    Scope  <\/p>\n<p>    - A snapshot of the global therapeutic scenario for Psoriasis.  <\/p>\n<p>    - A review of the Psoriasis products under development by    companies and universities\/research institutes based on    information derived from company and industry-specific sources.  <\/p>\n<p>    - Coverage of products based on various stages of development    ranging from discovery till registration stages.  <\/p>\n<p>    - A feature on pipeline projects on the basis of monotherapy    and combined therapeutics.  <\/p>\n<p>    - Coverage of the Psoriasis pipeline on the basis of route of    administration and molecule type.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Read the original here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/research-markets-psoriasis-pipeline-review-142700585.html;_ylt=AwrNUWxTamFRWWkAAQD_wgt.\" title=\"Research and Markets: Psoriasis - Pipeline Review, H1 2013\">Research and Markets: Psoriasis - Pipeline Review, H1 2013<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> DUBLIN--(BUSINESS WIRE)-- Research and Markets (<a href=\"http:\/\/www.researchandmarkets.com\/research\/8rr8vz\/psoriasis\" rel=\"nofollow\">http:\/\/www.researchandmarkets.com\/research\/8rr8vz\/psoriasis<\/a>) has announced the addition of the \"Psoriasis - Pipeline Review, H1 2013\" report to their offering. This report provides information on the therapeutic development for Psoriasis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Psoriasis <a href=\"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/transhuman-news-blog\/psoriasis\/research-and-markets-psoriasis-pipeline-review-h1-2013\/\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[22],"tags":[],"class_list":["post-12556","post","type-post","status-publish","format-standard","hentry","category-psoriasis"],"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/12556"}],"collection":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/comments?post=12556"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/12556\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/media?parent=12556"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/categories?post=12556"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/tags?post=12556"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}